The higher dosage of 10mg per peptide (compared to the standard 5mg individual vials) provides researchers with sufficient material for extended experimental timelines without the need for frequent reconstitution, reducing contamination risk and improving protocol consistency
In Heffernan et al
This guide walks through every detail of the reconstitution process, from the math behind different concentrations to the exact technique that prevents peptide degradation during mixing
Ongoing Monitoring and Evaluation We will monitor your progress on a weekly basis, making any necessary adjustments to ensure effectiveness
[DOI] [PubMed] [Google Scholar] 145.Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, et al
gentle warming and extended mixing may be required Do not use organic solvents (acetonitrile, DMSO) unless specifically validated for the peptide Solution is Cloudy or Precipitated Cloudiness may indicate peptide aggregation or poor solubility Try gentle warming to 37 C and slow cooling to room temperature If precipitation persists, the peptide may be degraded or the concentration too high Consider diluting to a lower concentration or using a different buffer (e.g., PBS with 0.1% BSA) Foam Formation Foam is caused by vigorous shaking or forceful injection of water Allow foam to settle naturally (do not shake to disperse) If foam persists, briefly centrifuge the vial at low speed (e.g., 500 g for 2 minutes) To prevent foam: inject water slowly down the vial wall
